The phrase pseudokinase was first coined in 2002.[9] They were subsequently sub-classified into different 'classes'.[10][8][11][12][13] Several pseudokinase-containing families are found in the human kinome, including the Tribbles pseudokinases, which are at the interface between kinase and ubiquitin E3 ligase signalling.[14][15][16]
The human pseudokinases (and their pseudophosphatase cousins) are implicated in a wide variety of diseases,[17][18] which has made them potential drug targets and antitargets).[19][20][21][22] Pseudokinases are made up of an evolutionary mixture of eukaryotic protein kinase (ePK) and non ePK-related pseudoenzyme proteins (e.g., FAM20A, which binds ATP[23] and is pseudokinase due to a conserved glutamate to glutamine swap in the alpha-C helix.[24] FAM20A is implicated in periodontal disease, and serves to control the catalytic activity of FAM20C, an important physiological casein kinase that controls phosphorylation of proteins in the Golgi apparatus that are destined for secretion,[25] such as the milk protein casein.
A comprehensive evolutionary analysis confirms that pseudokinases group into multiple subfamilies, and these are found in the annotated kinome of organisms across the kingdoms of life, including prokaryotes, archaea and all eukaryotic lineages with an annotated proteome; this data is searchable in ProKino (http://vulcan.cs.uga.edu/prokino/about/browser). [26]
^Murphy JM, Farhan H, Eyers PA (April 2017). "Bio-Zombie: the rise of pseudoenzymes in biology". Biochemical Society Transactions. 45 (2): 537–544. doi:10.1042/BST20160400. PMID28408493.
^Eyers PA, Murphy JM (August 2013). "Dawn of the dead: protein pseudokinases signal new adventures in cell biology". Biochemical Society Transactions. 41 (4): 969–74. doi:10.1042/BST20130115. PMID23863165.
^Reiterer V, Eyers PA, Farhan H (September 2014). "Day of the dead: pseudokinases and pseudophosphatases in physiology and disease". Trends in Cell Biology. 24 (9): 489–505. doi:10.1016/j.tcb.2014.03.008. PMID24818526.
^Bailey FP, Byrne DP, McSkimming D, Kannan N, Eyers PA (January 2015). "Going for broke: targeting the human cancer pseudokinome". The Biochemical Journal. 465 (2): 195–211. doi:10.1042/BJ20141060. PMID25559089.
^Foulkes DM, Byrne DP, Bailey FP, Eyers PA (October 2015). "Tribbles pseudokinases: novel targets for chemical biology and drug discovery?". Biochemical Society Transactions. 43 (5): 1095–103. doi:10.1042/BST20150109. PMID26517930.